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On p. 214, section 2.4., the last paragraph should have read: 
For the transfer of the monoiodo derivative of CMP-9-deoxy-9-salizoyl-Neck 100 pg IgG in 100 ~1 15 mM 
phosphate buffer, pH 7.0, 10 mU ol-2,6-ST (5 ~1) and 100 ,DI of the HPLC-fraction containing the radioactive substance 
were incubated. The reaction mixture for the transfer of the diiodo derivative consisted of 100 ,ug IgG in 100&l 15 mM 
phosphate buffer pH 7.0, 40 mU as-2,6-ST (20 ~1) and 200 ,ul of the HPLC-fraction containing the diiodo derivative. 
On p. 214, the legend to Fig. 4 should have read: 
o, 1 ,ug iodogen; q , 10 ,ug iodogen. 
On p. 215, right column, the first line shoutd have read: 
*.. the reaction with 1 or 10 pg iodogen was very fast . . . . 
On p. 215, right column, line 3 shozdd have read: 
For carrier added iodination we used vials with 100 pg iodogen, 
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The structure of Irsogladine presented in Fig. 1 was not correct. The correct structure is presented below. 
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Fig. 1. The structure of Irsogladine. 
